Reports and Recordings | Medicines Discovery Catapult

MDC Connects: A Guide to Drug Discovery

26 experts from MDC and our partners give their views on the latest developments in drug discovery

The Emerging Hearing Medicines Landscape Webinar Series – Webinar 4: The Challenges and Opportunities for Emerging Cell and Gene Therapy Approaches to Address Hearing Loss

A monthly webinar series developed by the Hearing Medicines Discovery Syndicate, exploring hearing drug discovery in an emerging area for medicines development, and a growing market. Through this series of webinars, we will explore the emerging hearing medicines landscape by inviting leading clinicians, academics and industry representatives along with people with lived experience of hearing […]

The Emerging Hearing Medicines Landscape Webinar Series – Webinar 3: “How and Why” to Commercialise your Hearing Research

The Emerging Hearing Medicines Landscape Webinar Series – Webinar 2: Challenges and opportunities of translational hearing research

The Emerging Hearing Medicines Landscape Webinar Series – Webinar 1: Addressing an unmet need

Webinar – Drug Repositioning for COVID-19

This seminar forms part of the AI3SD Online Seminar Series. In this seminar, Prof. John P. Overington briefly provides an overview of drug repositioning as a general strategy, and the focussed application of core concepts towards the treatment of COVID-19. Recording

Webinar – Developing a Biomarker Strategy

MDC Connects is a series of informative webinars covering the drug discovery process, from our own experts and experts at our CRO network partners. A common theme throughout our MDC Connects series is that of building confidence in a hypothesis and improving the chances of success in the clinic. To achieve success, the project team […]

Webinar – Is my Compound Safe?

MDC Connects is a series of informative webinars covering the drug discovery process, from our own experts and experts at our CRO network partners. Safety plays a huge part during preclinical development, and any drug must be extensively tested to regulatory standards before approval to test in humans. Safety-related hazards can arise from target-mediated risk, […]

Webinar – Target Validation and Efficacy

MDC Connects is a series of informative webinars covering the drug discovery process, from our own experts and experts at our CRO network partners. Project failure due to lack of clinical efficacy during development remains an issue and can in part be attributed to inadequate pre-clinical target validation or clinical translation data. Target validation is […]

Older posts